Table 2. Sociodemographic and Clinical Characteristics (n = 32).
| Characteristic | Value |
|---|---|
| Age, mean years ± SD | 58 ± 13 |
| Male Gender, % (n) | 78.1 (25) |
| Race/Ethnicity % (n) | |
| Caucasian/White | 59.4 (19) |
| African-American/Black | 31.3 (10) |
| Asian/Pacific Islander | 9.4 (3) |
| History of smoking, % (n) | 75.0 (24) |
| History of hypertension, % (n) | 71.9 (23) |
| Creatinine on admission (g/dL), mean ± SD | 1.9 ± 1.7 |
| Etiology of Heart Failure, % (n) | |
| Ischemic | 28.1 (9) |
| Idiopathic | 65.6 (21) |
| Unknown/other | 6.3 (2) |
| Ejection Fraction < 40%, % (n) | 71.9 (23) |
| ACEi/ARB use - study end, % (n) | 62.5 (20) |
| Beta blocker use - study end, % (n) | 78.1 (25) |
| High-Risk Diagnoses for the Elderly Scale (study end), mean ± SD | |
| Low (0) = 9.5% chance dying in 1 year | 3.3 ± 1.7 |
| Intermediate (1 - 2) = 31% chance | |
| High risk (3 - 5) = 46% chance | |
| Very High Risk (> 6) = 74% chance | |
| Length of hospital stay, mean in days ± SD | 9.5 ± 9.9 |
| Physical Therapy - in hospital, % (n) | 34.4 (11) |
| LVAD received during study admission, % (n) | 6.3 (2) |
| Discharged with Physical Therapy, Occupational Therapy, or Home Health, % (n) | 40.6 (13) |
| Cardiac Events - 90 days post-discharge, % (n) | |
| Cardiac readmission | 34.4 (11) |
| Heart transplant | 3.1 (1) |
| Mortality | 9.4 (3) |
ACEi: angiotensin converting enzyme inhibitor; ARB: angiotensin receptor blocker; LVAD: left ventricular assistive device.